| Primary |
| Malignant Melanoma |
58.0% |
| Pain |
8.2% |
| Diffuse Large B-cell Lymphoma |
4.7% |
| Meniere's Disease |
4.7% |
| Metastatic Malignant Melanoma |
3.5% |
| Anxiety |
3.1% |
| Malignant Melanoma Of Sites Other Than Skin |
2.3% |
| Hypercholesterolaemia |
1.6% |
| Hypersensitivity |
1.6% |
| Major Depression |
1.6% |
| Pruritus |
1.6% |
| Cough |
1.2% |
| Decreased Appetite |
1.2% |
| Myelodysplastic Syndrome |
1.2% |
| Nasopharyngeal Cancer |
1.2% |
| Premedication |
1.2% |
| Rash Erythematous |
1.2% |
| Addison's Disease |
0.8% |
| Breast Cancer |
0.8% |
| Hyperlipidaemia |
0.8% |
|
| Dehydration |
12.3% |
| Cardiac Arrest |
7.0% |
| Embolism |
7.0% |
| Fatigue |
7.0% |
| Hyperuricaemia |
7.0% |
| Arthritis |
5.3% |
| Diarrhoea |
5.3% |
| Dyspnoea |
5.3% |
| Hypotension |
5.3% |
| Death |
3.5% |
| Depression |
3.5% |
| Fall |
3.5% |
| Pain In Extremity |
3.5% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.5% |
| Rash |
3.5% |
| Sepsis |
3.5% |
| Sick Sinus Syndrome |
3.5% |
| Urticaria |
3.5% |
| Vomiting |
3.5% |
| Weight Decreased |
3.5% |
|
| Secondary |
| Malignant Melanoma |
48.9% |
| Diffuse Large B-cell Lymphoma |
12.3% |
| Pain |
6.8% |
| Meniere's Disease |
4.6% |
| Antifungal Prophylaxis |
3.8% |
| Major Depression |
3.6% |
| Anxiety |
2.0% |
| Vomiting |
1.9% |
| Hypothyroidism |
1.8% |
| Glioblastoma |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Malignant Melanoma Of Sites Other Than Skin |
1.5% |
| Pruritus |
1.5% |
| Premedication |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Myelodysplastic Syndrome |
1.2% |
| Nasopharyngeal Cancer |
1.2% |
| Rash Erythematous |
1.2% |
| Breast Cancer |
1.0% |
| Breast Cancer Metastatic |
1.0% |
|
| Cardiac Arrest |
19.1% |
| Rash |
10.0% |
| Dehydration |
9.1% |
| Adrenal Insufficiency |
8.2% |
| Sepsis |
6.4% |
| Fall |
5.5% |
| Diarrhoea |
4.5% |
| Embolism |
3.6% |
| Lipase Increased |
3.6% |
| Thrombosis |
3.6% |
| Blood Creatine Phosphokinase Increased |
2.7% |
| C-reactive Protein Increased |
2.7% |
| Dyspnoea |
2.7% |
| Enterocolitis Infectious |
2.7% |
| Hypocalcaemia |
2.7% |
| Hypotension |
2.7% |
| Pyrexia |
2.7% |
| Red Blood Cell Sedimentation Rate Increased |
2.7% |
| Syncope |
2.7% |
| Cerebrovascular Accident |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.4% |
| Prophylaxis |
10.1% |
| Hiv Infection |
6.1% |
| Breast Cancer |
4.5% |
| Medical Diet |
4.5% |
| Nausea |
4.5% |
| Acute Lymphocytic Leukaemia |
3.6% |
| Premedication |
3.2% |
| Anxiety |
2.8% |
| Chills |
2.8% |
| Pain |
2.8% |
| Hypovitaminosis |
2.4% |
| Pyrexia |
2.4% |
| Sedation |
2.4% |
| Diffuse Large B-cell Lymphoma |
2.0% |
| Neutrophil Count |
2.0% |
| Thrombocytopenia |
2.0% |
| Vomiting |
2.0% |
| Bone Marrow Conditioning Regimen |
1.6% |
| Bone Sarcoma |
1.6% |
|
| Thrombocytopenia |
14.8% |
| Pneumonia |
11.1% |
| Bacteraemia |
7.4% |
| Haemorrhage Intracranial |
7.4% |
| Ventricular Fibrillation |
7.4% |
| Vomiting |
7.4% |
| Aspartate Aminotransferase Abnormal |
3.7% |
| Atrial Fibrillation |
3.7% |
| Crohn's Disease |
3.7% |
| Cytomegalovirus Viraemia |
3.7% |
| Hypotension |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Malnutrition |
3.7% |
| Pneumothorax |
3.7% |
| Sinusitis |
3.7% |
| Thrombotic Stroke |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Transplant Failure |
3.7% |
|
